Skip to content
PubMed This is a summary of 24 peer-reviewed journal articles Updated
Cardiology

How Does Mitral Valve Stenosis Affect Life Expectancy?

At a Glance

Life expectancy with mitral valve stenosis varies with the severity and cause of narrowing, symptoms, heart and lung pressure, age, and other illnesses. Timely evaluation and appropriate treatment can relieve the obstruction, reduce complications, and improve the long-term outlook.

The long-term outlook and life expectancy for someone with mitral valve stenosis (a narrowing of the heart’s mitral valve) depend heavily on the severity of the narrowing, the underlying cause, and whether timely treatment is received. There is no single “life expectancy” number because the disease affects everyone differently [1][2]. While medications can manage symptoms, control heart rate, and reduce the risk of blood clots, they cannot physically open a narrowed valve [3]. Therefore, patients with severe disease require appropriate evaluation and intervention when indicated by medical guidelines. With timely treatment, many patients experience significant improvements in symptoms and long-term prognosis [4][5]. Without treatment, severe mitral stenosis progressively worsens and can lead to life-threatening complications.

The Natural History of Untreated Mitral Stenosis

If severe mitral stenosis is left untreated, the narrowing of the valve obstructs forward blood flow, causing pressure to rise in the left atrium. Over time, this elevated pressure backs up into the lungs and the right side of the heart. The natural progression of untreated severe disease can include:

  • Atrial Fibrillation (AFib): The left atrium stretches, often triggering this irregular heart rhythm. AFib worsens symptoms and significantly increases the risk of blood clots [1][6].
  • Pulmonary Hypertension: Pressure builds up in the blood vessels of the lungs. If it persists, it can cause changes to the lung vessels that may become difficult to reverse [7].
  • Right-Sided Heart Failure: As pressure in the lungs increases, the right side of the heart (the right ventricle) has to work against increased resistance and can eventually fail [1][8].
  • Embolic Stroke or Systemic Embolism: Stagnant blood in the enlarged left atrium can form clots, which can travel to the brain or other organs. The risk of clots can be substantial in rheumatic stenosis even if you are not aware of having atrial fibrillation [6][1].

Because modern medicine usually intervenes before the disease reaches its final stages, doctors no longer use a single “untreated life expectancy” timeline. However, historical data and modern observations confirm that delaying a needed intervention leads to poorer outcomes [3][2].

Factors That Influence Your Outlook

Your prognosis is highly individual. Doctors look at several key factors to estimate your risk and plan the best timing for treatment:

  • Severity and Symptoms: Patients with mild or moderate stenosis without symptoms often do well for years with careful monitoring. However, severe stenosis, especially when symptoms like shortness of breath develop, strongly signals that intervention is needed [9][10].
  • Valve Anatomy: Your doctor may calculate a Wilkins score, a tool that assesses the valve’s thickness, calcification, and mobility to determine if a rheumatic valve is suitable for a balloon procedure [11].
  • The Cause of the Stenosis:
    • Rheumatic Mitral Stenosis: Caused by prior rheumatic fever, this is the most common cause worldwide. The valve leaflets become thickened and fused. These valves often respond well to procedures that stretch them open [2].
    • Calcific (Degenerative) Mitral Stenosis: This occurs when calcium builds up on the valve over time, usually in older adults. Patients with this type often have other health conditions and older age, which makes their overall life expectancy lower and surgical interventions riskier [12][13][14].
  • Atrial Fibrillation: The presence of AFib is a marker for a higher-risk course. It increases the risk of stroke and is associated with poorer long-term results after valve procedures [6][15].
  • Pulmonary Pressure and Right Ventricle Health: High blood pressure in the lungs and reduced function of the right ventricle are signs that the heart is struggling to compensate [7][8][9].
  • Age and Other Medical Conditions: Co-existing diseases such as chronic kidney disease or chronic obstructive pulmonary disease (COPD) significantly impact overall life expectancy, particularly in older patients with calcific stenosis [13][16].
  • Access to Care: Timely evaluation at a specialized valve center is crucial. Delays in referral can leave patients at risk for severe complications [17][18].

Outcomes After Intervention

When medications are no longer enough, doctors will recommend a procedure to relieve the blockage. The choice of procedure depends on your anatomy, symptoms, and surgical risk.

Percutaneous Mitral Balloon Commissurotomy (PMBC)
Also known as PTMC, this minimally invasive catheter procedure uses a balloon to stretch the fused valve open. It is the preferred treatment for patients with favorable valve anatomy (usually rheumatic stenosis with pliable leaflets and little calcium) [2].

  • PMBC can provide immediate relief of symptoms, lowering pressures in the heart and lungs [4].
  • While it has potential benefits, it is not without risks. Complications such as significant new valve leakage (regurgitation), stroke, or the need for urgent surgery can occur [4][5].
  • The main limitation is that the valve can narrow again over time (restenosis). If the procedure is successful, patients may remain symptom-free for many years, but lifelong follow-up is necessary [19][20].

Valve Surgery
If the valve is heavily calcified, if there is a blood clot in the left atrium, or if there is significant leaking in addition to stenosis, PMBC may be unsuitable. For a left-atrial clot, doctors may first use blood thinners and repeat imaging; if it persists, or if the anatomy is unsuitable for balloons, open-heart surgery is considered. Calcific disease requires individualized assessment, as it can make surgery high risk.

  • Mitral Valve Repair: Surgical commissurotomy involves the surgeon physically opening the fused leaflets. Repairing the valve preserves the heart’s natural structures [21].
  • Mitral Valve Replacement: If the valve is too damaged to repair, it will be replaced. While replacement definitively treats the stenosis, it carries surgical risks and requires long-term management [22].

Medications and Monitoring

Anticoagulants (blood thinners) are prescribed for specific reasons, such as atrial fibrillation, a history of clots, or a mechanical valve replacement. For moderate-to-severe rheumatic mitral stenosis or mechanical valves, a specific vitamin-K antagonist (like warfarin) is usually required [23]. Never start, stop, or change these medications without your doctor’s guidance. Pregnancy and intense physical activity can also increase flow across the narrowed valve, so discuss activity and family planning with your cardiology team [24].

When to Seek Immediate Medical Attention

Do not wait for a routine appointment if you experience emergency symptoms. Seek immediate medical care or call 911 if you develop:

  • Rapidly worsening or severe shortness of breath, or an inability to lie flat
  • Fainting or severe dizziness
  • New chest pain
  • Coughing up pink or bloody froth
  • A new rapid or irregular heartbeat with symptoms
  • Signs of a stroke (facial droop, arm weakness, or speech difficulty)

Common questions in this guide

What determines life expectancy with mitral valve stenosis?
There is no single life-expectancy number for mitral valve stenosis. Outlook depends on how severe the narrowing is, its cause, symptoms, heart rhythm, pressure in the lungs, right-heart function, age, other illnesses, and whether treatment is provided when needed.
Can treatment improve the outlook for mitral valve stenosis?
Yes. Medicines can ease symptoms, control heart rate, and lower the risk of blood clots, but they do not open the narrowed valve. A balloon procedure, valve repair, or valve replacement may improve blood flow and symptoms when the person and valve anatomy are suitable.
What can happen if severe mitral stenosis is not treated?
The narrowing can raise pressure in the lungs and strain the right side of the heart. It may lead to an irregular rhythm called atrial fibrillation, heart failure on the right side, or blood clots that cause a stroke or other organ damage.
How does balloon treatment affect the prognosis?
A catheter-based balloon procedure can open a suitable valve damaged by rheumatic fever and quickly reduce pressure in the heart and lungs. Symptoms may improve for many years, but the valve can narrow again, and the procedure can cause leakage, stroke, or other complications, so follow-up is needed.
Will I need a blood thinner with mitral valve stenosis?
Blood thinners may be prescribed if you have atrial fibrillation, a previous blood clot, moderate-to-severe rheumatic mitral stenosis, or a mechanical replacement valve. Warfarin is commonly required in some of these situations, and you should not start, stop, or change it without your clinician’s guidance.
When are symptoms of mitral stenosis an emergency?
Seek emergency care for rapidly worsening shortness of breath, inability to lie flat, fainting, new chest pain, coughing up pink or bloody froth, or a fast or irregular heartbeat with symptoms. Facial drooping, arm weakness, or trouble speaking may signal a stroke and require an immediate call to emergency services.

Get notified when new evidence is published on mitral valve stenosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (24)
  1. 1

    Upstream and Downstream Cardiovascular Changes in Rheumatic Mitral Stenosis: An Update.

    Rudiktyo E, Teske AJ, Yonas E, et al.

    Journal of clinical medicine 2025; (14(8)) doi:10.3390/jcm14082639.

    PMID: 40283468
  2. 2

    Rheumatic Mitral Valve Stenosis: Diagnosis and Treatment Options.

    Wunderlich NC, Dalvi B, Ho SY, et al.

    Current cardiology reports 2019; (21(3)):14 doi:10.1007/s11886-019-1099-7.

    PMID: 30815750
  3. 3

    A study of Clinical Profile and in Hospital Outcomes of patients undergoing Percutaneous Transvenous Mitral Commissurotomy at a Tertiary Care Center of Nepal.

    Yadav S, Shah S, Gajurel RM, et al.

    Annals of medicine and surgery (2012) 2022; (84()):104867 doi:10.1016/j.amsu.2022.104867.

    PMID: 36536708
  4. 4

    Efficacy and safety of percutaneous mitral balloon valvotomy in patients with mitral stenosis: A systematic review and meta-analysis.

    Abu Rmilah AA, Tahboub MA, Alkurashi AK, et al.

    International journal of cardiology. Heart & vasculature 2021; (33()):100765 doi:10.1016/j.ijcha.2021.100765.

    PMID: 33889711
  5. 5

    Comparison of early and long-term follow-up results of percutaneous mitral balloon valvuloplasty and mitral valve replacement.

    Usta E, Erdim R, Görmez S, et al.

    Revista da Associacao Medica Brasileira (1992) 2021; (67(1)):58-63 doi:10.1590/1806-9282.67.01.20200277.

    PMID: 34161466
  6. 6

    Management of atrial fibrillation in patients with rheumatic mitral stenosis.

    Iung B, Leenhardt A, Extramiana F

    Heart (British Cardiac Society) 2018; (104(13)):1062-1068 doi:10.1136/heartjnl-2017-311425.

    PMID: 29453328
  7. 7

    Pulmonary Hypertension in Aortic and Mitral Valve Disease.

    Maeder MT, Weber L, Buser M, et al.

    Frontiers in cardiovascular medicine 2018; (5()):40 doi:10.3389/fcvm.2018.00040.

    PMID: 29876357
  8. 8

    Preprocedural Left Atrial Strain as a Predictor of Long-Term Outcomes Following Mitral Valve Interventions in Rheumatic Severe Mitral Stenosis.

    Yoon SG, Kim DY, Cho I, et al.

    Journal of the American Heart Association 2026; (15(2)):e043746 doi:10.1161/JAHA.125.043746.

    PMID: 41532539
  9. 9

    Mid-term (up to 12 years) clinical and echocardiographic outcomes of percutaneous transvenous mitral commissurotomy in patients with rheumatic mitral stenosis.

    Dadjo Y, Moshkani Farahani M, Nowshad R, et al.

    BMC cardiovascular disorders 2021; (21(1)):355 doi:10.1186/s12872-021-02175-3.

    PMID: 34320949
  10. 10

    Regional left ventricular strain recovery after percutaneous mitral balloon valvuloplasty: determinants and prognostic implications.

    Chavez LMT, Melo PHM, Pousa PA, et al.

    The international journal of cardiovascular imaging 2026; doi:10.1007/s10554-026-03821-7.

    PMID: 42754744
  11. 11

    Novel Prognostic Score for Immediate and Late Success After Percutaneous Mitral Balloon Commissurotomy in Patients With Mitral Stenosis.

    Prota-Filho LEB, Meneguz-Moreno RA, Queiroz CCV, et al.

    The Journal of invasive cardiology 2020; (32(6)):211-217.

    PMID: 32269178
  12. 12

    Mitral Annular Calcification-Related Mitral Stenosis: 5-Year Outcomes and Prognostic Determinants in the JAMAC Study.

    Kato N, Watanabe T, Ishihara T, et al.

    Journal of the American College of Cardiology 2026; (87(23)):3260-3273 doi:10.1016/j.jacc.2025.12.004.

    PMID: 41778951
  13. 13

    Degenerative mitral stenosis by echocardiography: presentation and outcome.

    Batista R, Benfari G, Essayagh B, et al.

    European heart journal. Cardiovascular Imaging 2024; (26(1)):118-125 doi:10.1093/ehjci/jeae246.

    PMID: 39301952
  14. 14

    Transatrial implantation of a transcatheter heart valve for severe mitral annular calcification.

    Praz F, Khalique OK, Lee R, et al.

    The Journal of thoracic and cardiovascular surgery 2018; (156(1)):132-142 doi:10.1016/j.jtcvs.2018.03.016.

    PMID: 29627180
  15. 15

    Poor outcome following percutaneous balloon mitral valvotomy in patients with atrial fibrillation.

    Aslanabadi N, Ghaffari S, Khezerlouy Aghdam N, et al.

    Journal of cardiovascular and thoracic research 2016; (8(3)):126-131 doi:10.15171/jcvtr.2016.26.

    PMID: 27777698
  16. 16

    Degenerative Mitral Stenosis Versus Rheumatic Mitral Stenosis.

    Pressman GS, Ranjan R, Park DH, et al.

    The American journal of cardiology 2020; (125(10)):1536-1542 doi:10.1016/j.amjcard.2020.02.020.

    PMID: 32241552
  17. 17

    Characteristics and immediate outcomes of patients who underwent percutaneous balloon mitral valvuloplasty at the Jakaya Kikwete Cardiac Institute, Tanzania.

    Mutagaywa RK, Cramer MJ, Chillo P, et al.

    Cardiovascular journal of Africa 2024; (35(1)):16-26 doi:10.5830/CVJA-2022-068.

    PMID: 36745007
  18. 18

    Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.

    Iung B, Delgado V, Rosenhek R, et al.

    Circulation 2019; (140(14)):1156-1169 doi:10.1161/CIRCULATIONAHA.119.041080.

    PMID: 31510787
  19. 19

    Independent Clinical and Echocardiographic Predictors of Restenosis After Percutaneous Mitral Balloon Commissurotomy in a Large, Consecutive Cohort Followed for 24 Years.

    Meneguz-Moreno RA, Ferreira-Neto AN, Gomes NL, et al.

    The Journal of invasive cardiology 2023; (35(3)):E113-E121 doi:10.25270/jic/22.00328.

    PMID: 36884359
  20. 20

    Percutaneous Transvenous Mitral Commissurotomy for Patients with Rheumatic Heart Disease.

    Li X, Zhu Y, Liang J, et al.

    International heart journal 2025; (66(1)):60-65 doi:10.1536/ihj.24-330.

    PMID: 39828335
  21. 21

    Long-Term Outcomes of Open Mitral Commissurotomy vs Mechanical Mitral Valve Replacement in Rheumatic Mitral Stenosis.

    Park I, Ahn JH, Sung K, et al.

    The Annals of thoracic surgery 2026; (122(2)):402-411 doi:10.1016/j.athoracsur.2026.03.018.

    PMID: 41865964
  22. 22

    Long-term outcomes of severe rheumatic mitral stenosis after undergoing percutaneous mitral commissurotomy and mitral valve replacement: A 10-year experience.

    Promratpan W, Theerasuwipakorn N, Lertsuwunseri V, Srimahachota S

    Journal of cardiovascular and thoracic research 2022; (14(2)):101-107 doi:10.34172/jcvtr.2022.16.

    PMID: 35935386
  23. 23

    Anticoagulation for rheumatic mitral stenosis, INVICTUS in perspective.

    Verma R, Latter DA

    Current opinion in cardiology 2023; (38(2)):55-60 doi:10.1097/HCO.0000000000001013.

    PMID: 36718615
  24. 24

    Comparative study on maternal and fetal outcome in pregnant women with rheumatic heart disease and severe mitral stenosis undergoing percutaneous balloon mitral valvotomy before or during pregnancy.

    Sharma JB, Yadav V, Mishra S, et al.

    Indian heart journal 2018; (70(5)):685-689 doi:10.1016/j.ihj.2018.01.018.

    PMID: 30392507

This page is for informational purposes only and does not constitute medical advice or predict your individual life expectancy. Discuss your prognosis, treatment timing, and emergency symptoms with your cardiology team.